CliniSys Group Creates Single Brand for UK and Europe

CliniSys GroupCliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website.

The move creates a unified identity for CliniSys in the UK and MIPS on the continent and underlines the group's commitment to providing end-to-end diagnostic systems to support safe and effective healthcare systems today and to drive medical innovation in the future.

Chair and chief executive Michael Simpson said: "The CliniSys Group is the largest diagnostic laboratory IT vendor in Europe. Our combined cross-discipline expertise, spanning more than 40 years, provides our customers with solutions that span the diagnostic journey.

"We have reached this position by following our core values: customer, promises, simplicity and teamwork - a commitment to providing customers with the best possible products, services and support. From late March, we have a new look but our values remain steadfast, and we look forward to continuing to care for our customers while working with them on the innovative solutions that we will all need for the future."

In the UK, CliniSys is known for its laboratory information management system which is installed in over 50% of NHS pathology laboratories. Tests for more than 40 million patients are processed on its order communications system every year with over 70% of NHS acute trusts using ICE for GP electronic requesting.

In October 2015, CliniSys was acquired by Roper Technologies and this has enabled it to add systems from complementary suppliers, such as Sunquest Information Systems and Data Innovations. This has enabled CliniSys to offer its UK customers industry-leading, end-to-end solutions, and to think creatively about meeting the needs of pathology networks, integrated care systems, and the coming world of precision medicine.

The CliniSys name is being retained in the UK, although the logo has been refreshed. Richard Craven, CliniSys chief executive, said: "Increasingly, CliniSys and MIPS have been working more collaboratively, launching common products such as our Genomics solution and developing our Cloud architecture and strategy. We have been one company for many years, and we felt now is the right time to bring our 40 year pedigree, track record and product proposition of the CliniSys Group together in one place and under one brand."

In Europe, MIPS is best known for its general laboratory information management system or GLIMS. This is the most widely used LIMS on the continent, where it is relied on by 15,000 people operating in 17 countries and ten languages.

MIPS also has a history of innovation. It has developed GLIMS Genomics as a LIMS to meet the needs of new, high-tech genetics laboratories, and seen it successfully deployed in Poitiers University Hospital. CliniSys recently brought GLIMS Genomics to the UK, which is developing its own network of genomic laboratory hubs.

CliniSys | MIPS will be the new brand for MIPS across Europe.

Alongside its new identity, CliniSys has launched a new website with information about its products, case studies highlighting the great work being done by its customers, and blogs about the development of pathology and diagnostic laboratory IT.

The website is at: www.clinisysgroup.com. There are no changes to the group's contracts, support services, product roadmap or release schedule.

About CliniSys Group

CliniSys Group is the largest laboratory diagnostic IT vendor in Europe, with leading country market shares and an innovative and wide-reaching suite of end-to-end diagnostic solutions.

Headquartered in England, with local offices in six European countries, it has for more than 40 years been at the forefront of diagnostics workflow, order communications and information management solutions supporting radiology, cardiology and all pathology disciplines including anatomical or cellular, molecular and genetics.

These encompass the complete workflow from order, clinical decision support, collection, processing, analysis, results and reporting, through integration into the clinical workflow. CliniSys Group has built an unrivalled reputation for the deployment of complex diagnostics networks and academic centres - and is the only vendor repeatably delivering across all disciplines end to end - at scale.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

Experts Propose Specific and Suited Guid…

Current Artificial Intelligence (AI) models for cancer treatment are trained and approved only for specific intended purposes. GMAI models, in contrast, can handle a wide range of medical data including...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...